Naguboyina Tejaswini, Lakkala Preethi, Munnangi Siva Ram, Vemula Sateesh Kumar, Repka Michael
Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, MS, 38677, USA.
Pii Centre for Pharmaceutical Technology, The University of Mississippi, University, MS, 38677, USA.
Pharm Res. 2025 Apr;42(4):685-696. doi: 10.1007/s11095-025-03859-7. Epub 2025 Apr 14.
Granulation is one of the important unit operations in the manufacturing of solid dosage forms like tablets and capsules that regulate the quality of end products. It is a process of particle enlargement by agglomeration technique, which improves flow properties, compressibility, reduction of dust formation, drug content uniformity, dissolution rates, and overall product stability. Traditionally, it has been a batch process due to a better understanding of the process. However, there has been a shift towards continuous manufacturing using a Twin-screw granulator, which is more robust, scalable, and versatile for a wide range of applications.
This work presents the innovative use of Twin screw wet granulation (TSWG) in the development of Quetiapine fumarate (QTF) immediate release tablets. Various process parameters (Screw configuration, liquid-to-solid (L/S) ratios), and binders (HPC and PVP) were evaluated to determine their effect on granule quality. Further, the obtained granules were tested for particle size distribution and flow properties.
A higher percentage of uniform-sized granules were yielded with three mixing zones even with a lower liquid addition compared to that of one mixing zone with a higher liquid addition. These granules were further tableted and tested for their hardness, friability, disintegration, and dissolution. The tablets disintegrated and released the drug (~ 95%) rapidly within 5 min in 0.1 N HCl due to QTF's high solubility and porosity of granules.
Overall, the understanding of process parameters and their influence on granule and tablet characteristics would help establish a more robust and continuous manufacturing of dosage forms.
制粒是片剂和胶囊等固体剂型制造中的重要单元操作之一,它能调节最终产品的质量。这是一种通过团聚技术使颗粒增大的过程,可改善流动性、可压性、减少粉尘形成、提高药物含量均匀性、溶解速率以及整体产品稳定性。传统上,由于对该过程有更好的理解,它一直是间歇式工艺。然而,目前已转向使用双螺杆制粒机进行连续制造,这种制粒机对于广泛的应用而言更坚固、可扩展且通用。
本文介绍了双螺杆湿法制粒(TSWG)在富马酸喹硫平(QTF)速释片开发中的创新应用。评估了各种工艺参数(螺杆配置、液固比)和粘合剂(羟丙基纤维素和聚乙烯吡咯烷酮),以确定它们对颗粒质量的影响。此外,对制得的颗粒进行了粒度分布和流动性测试。
与添加较高液体量的单混合区相比,具有三个混合区的情况下,即使液体添加量较低,也能产生更高比例的尺寸均匀的颗粒。将这些颗粒进一步压片,并测试其硬度、脆碎度、崩解度和溶出度。由于QTF的高溶解度和颗粒的孔隙率,片剂在0.1 N盐酸中5分钟内迅速崩解并释放药物(约95%)。
总体而言,了解工艺参数及其对颗粒和片剂特性的影响将有助于建立更稳健的剂型连续制造工艺。